Ryzodeg 70/30 (insulin degludec/insulin aspart) is a premixed insulin combination containing long-acting insulin degludec and rapid-acting insulin aspart.

Ryzodeg 70/30 is indicated to improve glycemic control in patients 1 year of age and older either type 1 or type 2 diabetes mellitus.

Diabetes mellitus is a disease in which the body does not produce enough insulin, or is unable to use insulin effectively. Ryzodeg 70/30 is a replacement for the insulin normally produced in the body and it works to regulate glucose metabolism.

Ryzodeg 70/30 contains two active ingredients:

• insulin degludec (absorbed slowly and has a long duration of action)
• insulin aspart (absorbed quickly and has a short duration of action)

Ryzodeg 70/30 is available as a FlexTouch pen. It is injected subcutaneously into the thigh, upper arm, or abdomen once or twice daily with any main meal.